市場調查報告書
商品編碼
1347411
幹細胞銀行市場:2023-2028 年全球行業趨勢、佔有率、規模、成長、機遇和預測Stem Cell Banking Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
2022年,全球幹細胞銀行市場規模達到74億美元。展望未來,IMARC Group預計到2028年市場規模將達到117億美元,2023-2028年年複合成長率(CAGR)為8.1%。
幹細胞庫是下一代幹細胞療法中最有前途也是成長最快的部分之一。這是提取、冷凍和儲存幹細胞以供未來使用的過程。獲得幹細胞的一些來源包括胚胎、臍帶、臍帶血、胎盤和骨髓。這些細胞用於治療多種不同的疾病,包括糖尿病、地中海貧血、白血病、鐮狀細胞性貧血和心臟病。此外,它們還用於產生血小板、紅細胞和白細胞。幹細胞的再生潛力導致其在組織工程、基因治療和再生醫學中的應用。
儘管由於醫學科學的進步,人類的平均預期壽命有所增加,但人類衰老仍然與多種疾病有關。因此,老年人口數量的增加將推動未來幾年對幹細胞治療的需求。
已開發地區和新興地區的監管機構和非政府組織 (NGO) 正在採取舉措,向消費者灌輸對幹細胞治療潛力的認知,從而影響幹細胞銀行市場的成長。
生育率的提高導致全球兒童數量的增加。這為保存含有造血(血液)幹細胞的嬰兒臍帶提供了有利可圖的機會。
促進市場成長的其他一些因素包括可支配收入的增加、幹細胞研究臨床試驗的批准增加、慢性病患病率的增加和技術進步。
The global stem cell banking market size reached US$ 7.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 11.7 Billion by 2028, exhibiting a growth rate (CAGR) of 8.1% during 2023-2028.
Stem cell banking is one of the most promising as well as the fastest growing segment of the next-generation stem cell therapy. It is the process of extracting, freezing and storing stem cells for potential future use. Some of the sources through which stem cells are obtained include embryo, umbilical cord, cord blood, placenta and bone marrow. These cells are used for treating a number of different diseases including diabetes, thalassemia, leukemia, sickle cell anemia and cardiac diseases. Moreover, they are also employed for generating platelets, red blood cells and white blood cells. The potential of stem cells to regenerate has led to their applications in tissue engineering, gene therapy and regenerative medicines.
While the average human life expectancy has increased owing to the advancements in medical science, human aging is still associated with several diseases. Thus, the elevating count of geriatric population will drive the demand for stem cell therapy in the coming years.
Regulatory authorities as well as non-governmental organizations (NGO), across both developed and emerging regions, are taking initiatives for instilling awareness amongst consumers about the therapeutic potentials of stem cells, thereby influencing the stem cell banking market growth.
Increasing fertility rates has led to a rise in the number of children across the globe. This offers lucrative opportunities for preserving the umbilical cord of infants which contains hematopoietic (blood) stem cells.
Some of the other factors which are catalyzing the growth of the market include escalating disposable incomes, increasing approval of clinical trials in stem cell research, growing prevalence of chronic diseases and technological advancements.
IMARC Group provides an analysis of the key trends in each segment of the global stem cell banking market report, along with forecasts at the global and regional levels from 2023-2028. Our report has categorized the market based on product type, service type, bank type, utilization and application.
Adult Stem Cells
Human Embryonic Cells
IPS Cells
On the basis of product types, the market has been segmented as adult stem cells, human embryonic cells and IPS cells. Presently, adult stem cells account for the majority of the market share as they help in repairing damaged tissues via cell division. In addition to this, adult stem cells offer advantages like ease of harvesting, high acceptance in the human body and effectiveness in tissue generation.
Sample Preservation and Storage
Sample Analysis
Sample Processing
Sample Collection and Transportation
Based on service types, the market has been segmented as sample preservation and storage, sample analysis, sample processing, and sample collection and transportation.
Private
Public
Based on the bank type, the market has been segregated as private and public stem cell banks. Private stem cell banks currently dominate the market, holding the largest share.
Used
Unused
Based on the utilization, the market has been segregated as used and unused.
Personalized Banking Applications
Research Applications
Clinical Applications
On the basis of application, the market has been segmented as personalized banking applications, research applications and clinical applications.
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
On a geographical front, North America enjoys the leading position in the global stem cell banking market on account of advancements in medical infrastructure and availability of federal funding for stem cell research. Other regions include Europe, Asia Pacific, Middle East and Africa, and Latin America.
CBR Systems Inc.
China Cord Blood Corporation
Cordlife
Cordvida
Cryo-Cell International, Inc.
Cryo-Save AG (A Group of Esperite)
Cryoviva India
Lifecell
Smart Cells International Ltd
Viacord